Newsroom

Newsroom

Evidence of BRAF V600E in indeterminate cell tumor and interdigitating dendritic cell sarcoma

Literature
Read More

Positive selection and high sensitivity test for MYD88 mutations using locked nucleic acid

Literature
Read More

Chimerism analysis of cell-free DNA in patients treated with hematopoietic stem cell transplantation may predict early relapse in patients with hematologic malignancies

Literature
Read More

NeoGenomics Completes Acquisition of Clarient, Inc.

Press Release
Read More

High sensitivity testing shows multiclonal mutations in patients with CLL treated with BTK inhibitor and lack of mutations in ibrutinib-naïve patients

Literature
Read More

NeoGenomics Launches New Liquid Biopsy Tests for Monitoring Solid Tumors and Predicting Resistance to BTK Inhibitors

Press Release
Read More

Classification of acute myeloid & myelodysplastic syndrome based on molecular profiling

Literature
Read More

Gene mutations in MDS associating with peripheral blood count abnormalities

Literature
Read More

Contact Us To Get Started!

Work with us – your premier oncology partner – to optimize cancer care for patients